Construction and expression of pLenti6/V5-R-K with CC-intrakine
SUN Li,ZHANG Ying,HUANG Chang-Xing,ZHANG Jiu-Cong,LIAN Jian-Qi,ZHANG Ye,WEI Xin,SUN Yong-Tao,BAI Xue-Fan
2009-01-01
Abstract:AIM: To study the HIV-based lentiviral vector,pLenti6/V5-R-K,which contained the gene CC-intrakine(RANTES-K) and to provide a basis for the gene therapy of HIV-1 infection.METHODS:A pLenti-based expression vector,pLenti6/V5-D-TOPO,was used to produce the lentiviral vector,which was cotransfected with the ViraPowerTM Packaging Mix(pLP1,pLP2,and pLP/VSVG) into 293FT cells to produce a replication-incompetent lentivius stock.After titrating the lentiviral stock using HeLa cells,the expression of the interest gene of RANTES was investigated by indirect immumofluorescence in transduced HeLa cells.RESULTS: The lentiviral expression vector,pLenti6/V5-R-K,was confirmed by enzymatic digestion and sequencing.The lentivirus stock was constructed in 293 FT cell line.The fluorescein was mainly scattered in cytoplasm and amph-nucleus in transduced HeLa cells.CONCLUSION: These findings demonstrate the ability of the lentiviral vector to transduce multiple genes into HeLa cells and its potential therapeutic roles in the treatment of HIV-1 infection.